SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-14-013732
Filing Date
2014-07-31
Accepted
2014-07-31 08:02:16
Documents
11
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q nby20140630_10q.htm 10-Q 1128293
2 EXHIBIT 31.1 ex31-1.htm EX-31 10564
3 EXHIBIT 31.2 ex31-2.htm EX-31 10402
4 EXHIBIT 32.1 ex32-1.htm EX-32 5056
5 EXHIBIT 32.2 ex32-2.htm EX-32 4887
  Complete submission text file 0001437749-14-013732.txt   8120596

Data Files

Seq Description Document Type Size
6 EXHIBIT 101.INS nby-20140630.xml EX-101.INS 1403230
7 EXHIBIT 101.SCH nby-20140630.xsd EX-101.SCH 56377
8 EXHIBIT 101.CAL nby-20140630_cal.xml EX-101.CAL 35074
9 EXHIBIT 101.DEF nby-20140630_def.xml EX-101.DEF 267950
10 EXHIBIT 101.LAB nby-20140630_lab.xml EX-101.LAB 438389
11 EXHIBIT 101.PRE nby-20140630_pre.xml EX-101.PRE 266793
Mailing Address 5980 HORTON STREET SUITE 550 EMERYVILLE CA 94608
Business Address 5980 HORTON STREET SUITE 550 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

IRS No.: 680454536 | State of Incorp.: CA | Fiscal Year End: 0120
Type: 10-Q | Act: 34 | File No.: 001-33678 | Film No.: 141004610
SIC: 2834 Pharmaceutical Preparations